APA (7th ed.) Citation

MD, H., KJ, B., HE, J., W, M., S, E., ZJ, K., . . . SP, S. (2024). Clinical application of plasma P-tau217 to assess eligibility for amyloid-lowering immunotherapy in memory clinic patients with early Alzheimer's disease. Research square. https://doi.org/10.21203/rs.3.rs-3755419/v1

Chicago Style (17th ed.) Citation

MD, Howe, et al. "Clinical Application of Plasma P-tau217 to Assess Eligibility for Amyloid-lowering Immunotherapy in Memory Clinic Patients with Early Alzheimer's Disease." Research Square 2024. https://doi.org/10.21203/rs.3.rs-3755419/v1.

MLA (9th ed.) Citation

MD, Howe, et al. "Clinical Application of Plasma P-tau217 to Assess Eligibility for Amyloid-lowering Immunotherapy in Memory Clinic Patients with Early Alzheimer's Disease." Research Square, 2024, https://doi.org/10.21203/rs.3.rs-3755419/v1.